DIN 02417472 — SIMPONI I.V. 50 MG
SIMPONI I.V. is a solution of Golimumab marketed by JANSSEN INC. The full Golimumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02417472
- Brand name
- SIMPONI I.V.
- Active ingredient
- Golimumab
- Strength
- 50 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- JANSSEN INC
- Health Canada status
- MARKETED
- Drug class
- Tumour necrosis factor alpha (TNFα) inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Golimumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02413175 | SIMPONI | 100 MG | SOLUTION | JANSSEN INC | MARKETED |
| 02413183 | SIMPONI | 100 MG | SOLUTION | JANSSEN INC | MARKETED |
| 02324776 | SIMPONI | 50 MG | SOLUTION | JANSSEN INC | MARKETED |
| 02324784 | SIMPONI | 50 MG | SOLUTION | JANSSEN INC | MARKETED |